|
Name |
Picolinamide
|
Molecular Formula | C6H6N2O | |
IUPAC Name* |
pyridine-2-carboxamide
|
|
SMILES |
C1=CC=NC(=C1)C(=O)N
|
|
InChI |
InChI=1S/C6H6N2O/c7-6(9)5-3-1-2-4-8-5/h1-4H,(H2,7,9)
|
|
InChIKey |
IBBMAWULFFBRKK-UHFFFAOYSA-N
|
|
Synonyms |
Picolinamide; 1452-77-3; PYRIDINE-2-CARBOXAMIDE; 2-Pyridinecarboxamide; Picolinoylamide; 2-Picolinamide; 2-Carbamoylpyridine; Picolinic acid amide; 2-aminocarbonyl-pyridine; alpha-Picolinamide; Pyridinecarboxamide; .alpha.-Picolinic acid amide; I3550CCL59; alpha - picolinamide; MFCD00023483; Pyridine-2-carboxamide (Picolinamide); NSC-524473; picolamide; pyridine amide; UNII-I3550CCL59; 2-picoloylamine; pyridyl carboxamide; EINECS 215-921-5; .alpha.-Picolinamide; Picolinamide, 98%; NSC 524473; 2-pyridine-carboxamide; pyridine 2-carboxamide; 2-picolinic acid amide; 2-pyridinecarboximidic acid; .alpha.-Pyridinecarboxamide; PICOLINAMIDE [INCI]; SCHEMBL61183; CHEBI:8200; DTXSID4061703; SCHEMBL11253275; SCHEMBL11256944; IBBMAWULFFBRKK-UHFFFAOYSA-; pyridine-2-carboxylic acid amide; HMS1784A15; ZINC388048; Picolinamide; 2-Pyridinecarboxamide; NSC524473; s4710; AKOS001144712; AM85589; CCG-266081; GS-6464; SY048638; DB-042775; HY-101020; CS-0020700; FT-0622194; P0414; C01950; A808344; J-008082; Q27107933; Z33546380; 2-Pyridinecarboxamide; Picolinoylamide; 2-Carbamoylpyridine; WM1
|
|
CAS | 1452-77-3 | |
PubChem CID | 15070 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 122.12 | ALogp: | 0.2 |
HBD: | 1 | HBA: | 2 |
Rotatable Bonds: | 1 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 56.0 | Aromatic Rings: | 1 |
Heavy Atoms: | 9 | QED Weighted: | 0.592 |
Caco-2 Permeability: | -4.336 | MDCK Permeability: | 0.00003240 |
Pgp-inhibitor: | 0.001 | Pgp-substrate: | 0.022 |
Human Intestinal Absorption (HIA): | 0.007 | 20% Bioavailability (F20%): | 0.003 |
30% Bioavailability (F30%): | 0.032 |
Blood-Brain-Barrier Penetration (BBB): | 0.99 | Plasma Protein Binding (PPB): | 23.32% |
Volume Distribution (VD): | 1.276 | Fu: | 77.83% |
CYP1A2-inhibitor: | 0.249 | CYP1A2-substrate: | 0.332 |
CYP2C19-inhibitor: | 0.029 | CYP2C19-substrate: | 0.061 |
CYP2C9-inhibitor: | 0.008 | CYP2C9-substrate: | 0.172 |
CYP2D6-inhibitor: | 0.004 | CYP2D6-substrate: | 0.381 |
CYP3A4-inhibitor: | 0.005 | CYP3A4-substrate: | 0.173 |
Clearance (CL): | 6.043 | Half-life (T1/2): | 0.268 |
hERG Blockers: | 0.084 | Human Hepatotoxicity (H-HT): | 0.099 |
Drug-inuced Liver Injury (DILI): | 0.909 | AMES Toxicity: | 0.019 |
Rat Oral Acute Toxicity: | 0.471 | Maximum Recommended Daily Dose: | 0.019 |
Skin Sensitization: | 0.127 | Carcinogencity: | 0.065 |
Eye Corrosion: | 0.011 | Eye Irritation: | 0.983 |
Respiratory Toxicity: | 0.506 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000056 | 0.667 | D0XF8W | 0.471 | ||||
ENC000585 | 0.488 | D06NVJ | 0.316 | ||||
ENC000048 | 0.429 | D0X9RY | 0.316 | ||||
ENC000076 | 0.429 | D07HBX | 0.300 | ||||
ENC000108 | 0.405 | D07ONP | 0.298 | ||||
ENC000219 | 0.359 | D09XQF | 0.293 | ||||
ENC005854 | 0.359 | D0R1CR | 0.289 | ||||
ENC001049 | 0.333 | D0MD2L | 0.286 | ||||
ENC000192 | 0.316 | D0D4CY | 0.281 | ||||
ENC000013 | 0.316 | D01ZJK | 0.273 |